Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -107 | -70 | -405 | -436 | -823 |
| Depreciation Amortization | 64 | 61 | 61 | 68 | 58 |
| Accounts receivable | -33 | -59 | -30 | 33 | 115 |
| Accounts payable and accrued liabilities | 30 | -82 | -28 | 49 | -66 |
| Other Working Capital | 73 | 28 | -75 | 152 | -17 |
| Other Operating Activity | 34 | 151 | 259 | 155 | 484 |
| Operating Cash Flow | $60 | $29 | $-217 | $21 | $-249 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -9 | -3 | -38 | -62 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 10 |
| Investing Cash Flow | $-4 | $-9 | $-3 | $-38 | $-53 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 61 | 63 | 229 | 10 | 80 |
| Other Financing Activity | -69 | -63 | -63 | 52 | 207 |
| Financing Cash Flow | $-8 | $0 | $166 | $62 | $287 |
| Beginning Cash Position | 57 | 37 | 91 | 46 | 61 |
| End Cash Position | 106 | 57 | 37 | 91 | 46 |
| Net Cash Flow | $48 | $20 | $-54 | $45 | $-15 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60 | 29 | -217 | 21 | -249 |
| Capital Expenditure | -4 | -9 | -3 | -38 | -62 |
| Free Cash Flow | 56 | 20 | -220 | -17 | -311 |